CONTRAVE
CONTRAVE
Approved
DIN Number
02472945
Drug Class
Human
Market Date
Mar 16, 2018
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02472945
AIG Number0259950001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A08AA62 BUPROPION AND NALTREXONE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:20.08.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
BUPROPION HYDROCHLORIDEActive
Strength: 90 MG
Monograph: BUPROPION HYDROCHLORIDE
NALTREXONE HYDROCHLORIDEActive
Strength: 8 MG
Monograph: NALTREXONE HYDROCHLORIDE